Decision Aid and Thyroid Nodules Management
Decision Aid for Management of Thyroid Nodules and Early Thyroid Cancer
1 other identifier
interventional
134
1 country
1
Brief Summary
Patients with small favorable malignant or indeterminate thyroid nodules will receive information about management of thyroid nodules. Participants will be asked to complete brief surveys at the time of enrollment, shortly after the consultation appointment with the surgeon, and a few months after either the consultation or the surgery, to assess their satisfaction with their decision and decision making process. All participants will receive routine care and counseling by their endocrinologist and surgeon.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Feb 2022
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 8, 2022
CompletedFirst Submitted
Initial submission to the registry
February 17, 2022
CompletedFirst Posted
Study publicly available on registry
March 3, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
September 30, 2027
October 14, 2025
October 1, 2025
5.6 years
February 17, 2022
October 10, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Rate of congruence between informed values and treatment choice
Percent of patients with congruence between treatment option and informed values based on a survey
6 months from surgery or surgical consultation date
Study Arms (1)
Thyroid nodule information
EXPERIMENTALInterventions
Participants will receive information about thyroid nodules and their management
Eligibility Criteria
You may qualify if:
- Histology showing indeterminate or malignant thyroid pathology (Bethesda III-VI)
- Thyroid nodule size less or equal to 2cm
You may not qualify if:
- History of thyroid surgery
- History of thyroid cancer
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Stony Brook University Cancer Center
Stony Brook, New York, 11794, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Lukasz Czerwonka, MD
Lukasz.Czerwonka@stonybrookmedicine.edu
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Head and Neck Surgeon
Study Record Dates
First Submitted
February 17, 2022
First Posted
March 3, 2022
Study Start
February 8, 2022
Primary Completion (Estimated)
September 30, 2027
Study Completion (Estimated)
September 30, 2027
Last Updated
October 14, 2025
Record last verified: 2025-10
Data Sharing
- IPD Sharing
- Will not share